The Pharmacokinetics and Local Tolerability of a Novel Sublingual Formulation of Buprenorphine-Reference-Cited by-同舟云学术

The Pharmacokinetics and Local Tolerability of a Novel Sublingual Formulation of Buprenorphine

Published:2018-01-03 Issue:1 Volume:20 Page:143-152
ISSN:1526-2375
Container-title:Pain Medicine
language:en
Short-container-title:

Author:

Lim Stephen Chin Beng¹,Schug Stephan²³⁴,Krishnarajah Janakan¹

Affiliation:

1. iX Biopharma Pty Ltd, Willetton, Western Australia

2. Medical School

3. Royal Perth Hospital

4. UWA Anaesthesiology, Perth, Western Australia

Funder

iX Biopharma Pty Ltd, Australia, manufacturer of sublingual buprenorphine

Publisher

Oxford University Press (OUP)

Subject

Anesthesiology and Pain Medicine,Clinical Neurology,General Medicine

Link

http://academic.oup.com/painmedicine/article-pdf/20/1/143/27495516/pnx321.pdf

Reference43 articles.

1. Double-blind, multidose comparison of buprenorphine and morphine in postoperative pain;Tigerstedt;Acta Anaesthesiol Scand,1980

2. The study of analgesics following single and repeated doses;Wang;J Clin Pharmacol,1981

3. Multidose/observational, comparative clinical analgesic evaluation of buprenorphine;Mok;J Clin Pharmacol,1981

4. Mechanism-based pharmacokinetic–pharmacodynamic modeling of the antinociceptive effect of buprenorphine in healthy volunteers;Yassen;Anesthesiology,2006

5. Comparative analysis of buprenorphine- and norbuprenorphine induced analgesic effects based on pharmacokinetic pharmacodynamic modelling;Ohtani;J Pharmacol Exp Ther,1995

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Verification of a Full Physiologically Based Pharmacokinetic Model for Sublingual Buprenorphine in Healthy Adult Volunteers that Accounts for Nonlinear Bioavailability;Drug Metabolism and Disposition;2024-05-20

2. A randomized controlled study to compare analgesic efficacy of sublingual buprenorphine and intravenous tramadol in patients undergoing mastectomy;Medical Gas Research;2023

3. Current and Future Therapeutic Options in Pain Management: Multi-mechanistic Opioids Involving Both MOR and NOP Receptor Activation;CNS Drugs;2022-05-26

4. Physiologically‐Based Pharmacokinetic Modeling to Investigate the Effect of Maturation on Buprenorphine Pharmacokinetics in Newborns with Neonatal Opioid Withdrawal Syndrome;Clinical Pharmacology & Therapeutics;2021-11-21

5. Buprenorphine for Chronic Pain: A Safer Alternative to Traditional Opioids;Health Psychology Research;2021-08-06